1C
ISEE

1623 Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

1623 Capital’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-20,000
Closed -$334K – 68
2021
Q4 		$334K Sell
20,000
-40,233
-67% -$659K 0.12% 57
2021
Q3 		$978K Buy
+60,233
New +$656K 0.38% 40

Other funds holding ISEE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

1623 Capital's ISEE Position: Q1 2022 in Review

1623 Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2022, closing a stake of 20,000 shares — an estimated $334K sold.

1623 Capital first reported a position in ISEE in Q3 2021 and held it in 2 quarters. The position peaked at $978K in Q3 2021. 163 funds tracked by Wall St. Rank hold ISEE as of Q1 2022.

  • 1623 Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • 1623 Capital sold 20,000 IVERIC bio, Inc. Common Stock shares in Q1 2022, an estimated $334K.
  • 1623 Capital first reported a position in IVERIC bio, Inc. Common Stock in Q3 2021 and held it in 2 quarters.
  • 1623 Capital's IVERIC bio, Inc. Common Stock position peaked at $978K in Q3 2021.
  • 163 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2022.

Based on 1623 Capital's 13F filing for Q1 2022, filed 13 May 2022.